chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had fever on 4-26-23 & irritable, sore at injection site. He was sluggish & w/ headache 3 days post vaccination. After 5 days, post vaccination he had hives on torso & spread to his arms, thighs & face Hives - off & on, did not completely went away Mom was giving Vit C, home remedy - cool baths & compress
No adverse event; lot that had been expired was administered to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (lot that had been expired was administered to patients) and NO ADVERSE EVENT (No adverse event) in a 63-year-old female patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (lot that had been expired was administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (lot that had been expired was administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (lot that had been expired was administered to patients).    Patient age was reported as 63 Year 7 Months.  No concomitant medication was provided.  N  umber was reported as 80777027399.   Lot number O70H21A was administered to patient between 08-Apr-2022 and 15-Dec-2022.  Treatment medication was not provided by the reporter.
patient stated that a day or 2 after  the vaccine his right arm was numb and tingling the whole arm was affected
This spontaneous report was received from a registered nurse reporting on a 22-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On 04-MAY-2017, the patient was vaccinated with improperly stored dose of VARIVAX injection (dose, frequency and route of administration were not reported, lot # either L050561 with expiration date of 14-DEC-2017 or M019841 with expiration date of 20-APR-2018), for prophylaxis. The Merck (MRK) sterile diluent (lot # and expiration date were not reported) used to reconstitute the VARIVAX was properly stored. The temperature excursion ranged from 6 to 14 degrees Fahrenheit and lasted for 30 minutes. It occurred on 03-FEB-2017, and then again on 18-APR-2017, and was detected by a Digital Data Logger. No adverse effects were reported. This was one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA010916: US-009507513-1704USA009837:
General feeling of "flu-like" symptoms, very, very tired. Had trouble staying awake while driving, night sweats, drained, trouble concentrating while reading, muscle soreness, body aches and pains: wrist, knee, ankle. Symptoms have subsided but still exists. Had 2nd shot on 6/12/00.
pt states that her arm was very sore after getting the vax.  Her arm is still sore today but was severely sore for a week and half.  She gets a chronic migraine every day since taking this vax.  She says the headache comes on about 10 AM everyday and it may last about 30 minutes or it may last a couple of hours.  She has bouts of vomiting that comes and goes.  she says the vomit contains blood.  When she vomits her face breaks out into a rash.  Pt says she is not feeling well, has chills and very fatigued.  These symptoms have been going on for almost 2 weeks.  Pt will see her PCP next week for symptoms on 4/14 @ 10AM.
Pt was seen outpt with abscess for 2 days she was hospitalized 8/30/07. She was set home on Clindamycin. She received IV Clindamycin.  09/10/2007 MR received from hospital for DOS 8/30-9/1/2007 for DX of Abscess on the L arm at the injection site. Started on po abx at PCP's office however is now having increased discharge.  Also c/o joint pain. PE (+) for erythematous papular rash on the torso as well as injection site redness and tenderness. Improved on IV abx. Joint pain resolved.
9/12 10 yo female came in for exam noted in vaccine record present by mother lack appropriate vaccine for age. When ask mother if any other vaccine record available or given beside listed denied. Pt therefore given Tdap, Hep B varicella,PPD, IPV. Last vaccine (Varicella) given patient noted became pale in color, tremor, decreased alertness, lasting seconds. Pt. crying after noticed by nurse and parent. Pt foaming from mouth, no lose of urine or stool. Patient afterward no increase sleepiness, pain. Able to communicate. Observed for 1 hour then sent home. Follow up in am.
Onset of  symptoms on 8/11/21 with cough, sore throat, and fever. Test results on 8/13/211 positive.  Isolation until 8/22/21 per DOH.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site hemorrhage in a 69-year-old female patient who received SHINGRIX (batch number HM3NC, expiry date 13th April 2021) for prophylaxis. On 11th January 2019, the patient received the 1st dose of SHINGRIX. On 11th January 2019, 1 min after receiving SHINGRIX, the patient experienced injection site hemorrhage and injection site pain. On 11th January 2019, the outcome of the injection site hemorrhage was recovered/resolved. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site hemorrhage and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient received the dose of SHINGRIX on an unknown arm. The injection site began to bleed as the needle was released from the arm. The pharmacist consented to follow up.
After receiving the vaccine his arm is sore and he can't lift his arm or his hand. He is not able to participant in sports at this time. He went to the doctor and he was advised the shot was not administered correctly, it was given to deep and it damaged the muscle underneath.
This spontaneous report as received fro a physician via company representative refers to an elderly female patient. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (route and site of administration, dose, not number and expiration date were not reported) however it is not documented in her medical record. On an unknown date, the patient developed shingles on her face and complained of pain in her face. The patient sought medical attention via physician visit and was treated with unspecified "antivirals and steroids" and gabapentin. The outcome of herpes zoster and facial pain was unknown. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
After receiving the vaccine, I developed a slight pain in the area where I had the vaccine. It became swollen and painful. It grew to the size of a tennis ball size. I took TYLENOL for the pain and the swelling. The pain was reduced after a day but lasted for about a week. The area became itchy where I wanted to scratch it. I completely recovered after one week.
I never experienced any reaction to flu shots or any other immunizations, but after the PPSV23 shot was given on April 24th, 2018, at 2:30pm, I noticed symptoms developing about 2 or 3 hours after the injection, I developed flu-like symptoms and pain in the right arm where the shot was given. For 3 days now, I have taken 800mg of Ibuprofen and 1000mg of acetaminophen for the pain and fever. Also, ice packs every few hours for the heat/swelling in my arm. Today/Friday April 27th, I am feeling a little better, but still have a little weakness and reduced amount of pain in the right arm at injection site. I have thought of going to the ER, but my symptoms have improved so I have not gone.
Patient was administered 1st dose on March 2018; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 90-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in March 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 26-May-2022 Reporter's comments: The patient wanted to get 2nd dose of Shingrix. The consent to follow up was given. Lot number and expiration date information of 1st dose was asked but was not available. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Achiness, cough, and fatigue beginning about half an hour after the shot.  Increasing in severity through the next day.  Spent 1/20 in bed.  Better now, though still a bit achy.
She seems to not have the feeling of intimacy since receiving the vaccine.; This is a spontaneous report from a contactable consumer or other non healthcare professional. A female patient of an unspecified age received bnt162b2 (Pfizer BioNTech COVID-19 mRNA Vaccine, Solution for Injection, Lot/Batch Number: Unknown), dose 1 via an unspecified route of administration on 30Apr2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included cortisone (CORTISONE) taken for an unspecified indication on 14May2021. The patient seems to not have the feeling of intimacy since receiving the vaccine. Patient has read information that the Pfizer Covid 19 Vaccine changes the genes in the body and ask if there's any reports on the Pfizer Covid 19 Vaccine effecting the ability to have kids. The outcome of the event was reported as unknown.  Information on Batch/lot number has been requested
severe body aches, fever of 101.7, headache, chills, shivering, dizziness
little soreness where he had the shot the 3 times he received the shots; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (little soreness where he had the shot the 3 times he received the shots) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (little soreness where he had the shot the 3 times he received the shots). At the time of the report, VACCINATION SITE PAIN (little soreness where he had the shot the 3 times he received the shots) outcome was unknown.            No concomitant medications or treatment details were reported.   This case was linked to MOD-2021-375356, MOD-2021-375381 (Patient Link).
Aoprox 2 weeks after admin patient is experiencing achiness in left arm, especially upon awaking in the morning.
pt screaming uncontrollably, inject site red, swollen 130PM; pt mom notified clinic; pt brought back to clinic, examined by MD given DPH;
10/2/09 received flu shot at work. Arm sore for days. 10/3/09 severe headache, nausea photophobia. 10/9/09 awoke syncopal episode sever vertigo that has lasted 6 months head CT done. 10/11/09 Head congestion started antibiotics Z PACK. 10/23/09 symptoms head pressure, memory problems, fatigue, chills. Nerve pain L arm L leg ear tinnitus intolerance to loud noises difficulty concentrating. 10/29 severe low back pain. Urinary retention. Treated LEVAQUIN, Prednisone. Nov 11, 2008 low magnesium level. Nov 12 2008  Brain MRI ordered. Dec 2008 saw ENT. Sent to vestibular Rehab. Increase numbness left side face. Began walking with wide gait poor balance weakness left side body. Currently: Remain ill unable to work due to ongoing symptoms as listed below. Tethered spinal cord surgery symptoms unresolved. Diagnosis: Pseudo tumor cerebri, central vertigo. taking DIAMOX, hereditary connective tissue disorder unknown type. Numbness, weakness, fatigue, chills, clumsiness, tingling, memory, concentration problems, lighthead. L side hearing decreased. Balance problems, swallowing difficulty, joint pain, tinnitus. Weight loss, nausea, urinary bowel difficulty. Any further details needed please contact. I have seen multiple specialist since onset of symptoms in 10/2008. 12/02/09 Medical records received DOS 10/20/09 Pt. presents with c/o urinary frequency/urgency, nocturia, insomnia, nausea x 4 days Diagnosis: Urinary tract infection  12/18/09 ED records received for DOS 10/09/08. Pt. presented with lightheadedness, syncopal episode at home in morning. DC home stable DX: vertigo, benign, positional 12/24/09 DC summary received for DOS 08/07/09-08/10/09.  12/24/09 DC summary received for DOS 09/18/09-09/21/09.    12/24/09 DC summary received for dates 8/7/09/ to 8/10/09. DX: tethered cord syndrome.  12/24/09 DC summary received for dates 9/18/09 to 9/21/09. DX: surgical report, lumbar drain placed. 12/28/09 Hosp records received for dates 1/6/09 to 1/7/09. DX: chest pain.Chief c/o left sided chest pain x2 days.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 67-year-old male patient who received SHINGRIX (batch number 539A2, expiry date 30th March 2020). On 9th March 2018, the patient received the 1st dose of SHINGRIX. In March 2018, 7 hrs after receiving SHINGRIX, the patient experienced fever (serious criteria other: as per reporter), erythema of extremities (serious criteria other: as per reporter), pustule (serious criteria other: as per reporter) and appetite lost (serious criteria other: as per reporter). The patient was treated with ibuprofen, TYLENOL and antihistamine. On an unknown date, the outcome of the fever, erythema of extremities, pustule and appetite lost were recovered/resolved. It was unknown if the reporter considered the fever, erythema of extremities, pustule and appetite lost to be related to SHINGRIX. Additional details were reported as follows: Several hours after vaccination, the patient experienced loss of appetite, arm redness and arm pustule. The patient required TYLENOL, Ibuprofen and an antihistamine as an intervention for the symptoms and recovered after 3 days. This case was one of the 3 cases reported by the same reporter.
PATIENT PREVIOUSLY RECIEVED 1 DOSE OF PFIZER VACCINE (1/7/2021-LOT EJ1685) FACILITY SPOKE TO PRESCRIBER SINCE THE PFIZER DOSE WAS NOT AVALIABLE FOR THE RESIDENT.  PRESCRIBER ADVISED THEM TO ADMINISTER JANSSEN TO VACCINATE RESIDENT
Diarrhea; Liitle sore; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Liitle sore), NAUSEA (Nausea) and VOMITING (Vomiting) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ). Concomitant products included LEVOTHYROXINE and HYDROCHLOROTHIAZIDE for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Liitle sore), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Liitle sore), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.            No treatment information were reported.  Action taken with the drug in response to events was not applicable.
Warm, itchy red patch approximately 2 inches below vaccine site. Swollen, itchy, erythametous, and warm to touch, painful. Tired.
Sore shoulder at injection site after 12 hours, aching joints.  Aching joints lasted until I took a couple of Advil and went away within 30 minutes.  Soreness and symptoms showed no evidence in the first 12 hours.  Sore shoulder lasted 3 days, was not debilitating.
Pain and swelling at the site, left upper arm and shoulder blade, lasting 2 weeks Loss of full range of motion in left arm continuing today (4 months) Left upper arm continues to feel bruised (4 months) Chills, fever, body aches, multiple hallucinations lasting 2 days Fatigue, lethargy continuing today (4 months) Daily Multiple silent migraines lasting two months Severe cramps all over body - neck, legs, arms, abdomen (4 months)
Low grade temp., extreme soreness in upper arm, hurts to move. Ibuprofen for fever, bedrest, not use arm, red swath across upper arm,  temp gone, soreness easing but redness still apparent after 2 days.
The flu shot was immediately very painful; I get the shot every year, and this was more painful than usual, by far. I also noticed how high it was on my arm---MUCH higher than I've ever seen before. For the first 3 days I had intense pain whenever I used the arm. After 3 days the intense pain decreased, but I still had very sharp pain when I lifted my arm or reached out in front of me or pushed out in any direction. This stayed constant for about a month and then the pain worsened in the areas all around my shoulder, particularly the back of my shoulder blade and my trapezoid. I was now in constant pain at a 3 or a 4 and still had sharp pain on lifting the arm overhead. At that time I started PT. I got an MRI (see below) which showed subacromial bursitis and fluid around some tendons. I received a cortisone shot to the subacromial bursa, which was ineffective. For another 2 months (we are at about month 3 now) the pain was constant and PT helped a little; anti-inflammatories helped a lot at high doses. At 4 months I flew out of state to see another doctor who used ultrasound imaging and he felt the location of the shot was a direct hit to the teres minor tendon insertion and he also saw a minor defect of the bone where the shot hit. He injected a lidocaine/saline solution to the exact spot under ultrasound guidance and I had temporary relief while the lidocaine was in effect (I could reach overhead, etc without pain). On my return my PT readjusted based on this information. At about 5 months some of the constant pain began to decrease, especially in the surrounding areas, but still had sharp pain on reaching overhead. At 6 months (now) this is the state---sometimes I have dull achey pain in the greater shoulder/shoulder blade/neck region at rest, but it's not constant; and I still have very sharp pain when I reach overhead. The original orthopedist now recommends surgery.
High pitched non stop crying for > 3 hours that started after parents got home from vaccines - about  1 hour afterward to my recollection.   Recovered after this time without longer term issues now 3 weeks later.
unknown if Moderna or Pfizer.  Altered mental status that increased and led to hospitalization.
Day 1  Oct 15th  tiredness and a little weakness.  Day 2 Oct 16 Headache, joint pain in knees, lower back,  hips, fingers.  Had a quivering/moving halo around everything,   My heart rate also kept beating fast.  Heart rate is usually in the 70's/80's for 0ct 16th and 17th it was in the high nineties.  It would come and go through out the day.,  I kept getting waves of this awful feeling like I was extremely sick with the flu.  I felt this way through Oct 17,
This spontaneous report as received from a licensed practical nurse refers to a 17 year old female patient with ATIVAN, KEPPRA, BENADRYL and COMPAZINE allergy and seizures that had been controlled with medication and diet. On 01-JUL-2013 the patient was vaccinated with the first dose of GARDASIL lot # H021346, 0.5 ml, intramuscular. Concomitant therapies included TOPAMAX, ZOLOFT and clonazepam. The patient had three seizures (medically significant) since received the vaccine. The nurse reported that the patient had two seizures on 01-JUL-2013 and one seizure on 02-JUL-2013. The nurse also stated that she was unsure of when the patient had a seizure last prior to receiving the GARDASIL. The nurse reported that the patient was in the physician office at the time of the call and that no particular treatment had been given yet. No lab was performed. Outcome of the patient and causality was not reported. Additional information has been requested.
Patient reports nausea, dizziness and headaches 2 days.  Saw doctor - loss of duty for 24 hours.
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Anaphylaxis-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild
On June 21, at approximately 8:30 a.m., my husband started with chest pain going thru to his back, he could not take the pain, saying that he felt very bad, which we had to take him to the nearest hospital to the emergency room. On the way he vomited, having sweats and arriving at the hospital he said that he could not walk, I brought him a wheelchair and he went into the hospital telling me that one foot felt cramp and numb that he could not move it, after the doctors checked him and two hours later he told me that he no longer feel both legs. Since that day he could not  move from his stomach down to the tips of his feet,  And after a few days and several tests they could not find any reason why he had  paralysis, the doctor said that it was a syndrome called Guillen Barré and to date he is still hospitalized without being able to move his feet and waiting for help to receive  therapy since we do not have the monetary resources for these services.
Pfizer-BioNTech Vaccine administered / COVID-19 test positive result; Pfizer-BioNTech Vaccine administered / COVID-19 test positive result; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for COVID-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Pfizer-BioNTech Vaccine administered / COVID-19 test positive result". The patient underwent the following laboratory tests and procedures: COVID-19 test: positive, notes: positive test result after recovery; negative, notes: negative test results.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Premature development of the breasts E30.8: Other disorders of puberty  Goals Patient Instructions will continue to observe and wil recheck at the next exam visit Discussion Notes This breast tissue development is most likely from the maternal hormones that developed during mom's pregnancy. the breast tissue should gradually go away